Changing the world

In the third episode of this podcast series, UCLB Director of BioPharm, Dr Richard Fagan, is in conversation with the co-founder of UCL spinout Achilles Therapeutics, Professor Charles Swanton. They discuss Achilles Tx’s achievements and how TRACERx, the first study to track the evolution of cancer cells, will help us beat cancer.

Roctavian is a world-first gene therapy for haemophilia A, with a ‘one and done’ treatment approach that could provide life-changing benefits to patients.